These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
99 related articles for article (PubMed ID: 32920426)
1. Nonpeptidic quinazolinone derivatives as dual nucleotide-binding oligomerization domain-like receptor 1/2 antagonists for adjuvant cancer chemotherapy. Ma Y; Yang J; Wei X; Pei Y; Ye J; Li X; Si G; Tian J; Dong Y; Liu G Eur J Med Chem; 2020 Dec; 207():112723. PubMed ID: 32920426 [TBL] [Abstract][Full Text] [Related]
2. Discovery of 1,4-Benzodiazepine-2,5-dione (BZD) Derivatives as Dual Nucleotide Binding Oligomerization Domain Containing 1/2 (NOD1/NOD2) Antagonists Sensitizing Paclitaxel (PTX) To Suppress Lewis Lung Carcinoma (LLC) Growth in Vivo. Wang S; Yang J; Li X; Liu Z; Wu Y; Si G; Tao Y; Zhao N; Hu X; Ma Y; Liu G J Med Chem; 2017 Jun; 60(12):5162-5192. PubMed ID: 28541685 [TBL] [Abstract][Full Text] [Related]
3. Identification of benzofused five-membered sultams, potent dual NOD1/NOD2 antagonists in vitro and in vivo. Ma Y; Li X; Pei Y; Ye J; Wei X; Yang J; Si G; Tian J; Dong Y; Liu G Eur J Med Chem; 2020 Oct; 204():112575. PubMed ID: 32731185 [TBL] [Abstract][Full Text] [Related]
4. Activation of the nucleotide oligomerization domain signaling pathway by the non-bacterially derived xanthone drug 5'6-dimethylxanthenone-4-acetic acid (Vadimezan). Cheng G; Sun J; Fridlender ZG; Wang LC; Ching LM; Albelda SM J Biol Chem; 2010 Apr; 285(14):10553-62. PubMed ID: 20118240 [TBL] [Abstract][Full Text] [Related]
5. Nucleotide-binding oligomerization domain (NOD) inhibitors: a rational approach toward inhibition of NOD signaling pathway. Jakopin Ž J Med Chem; 2014 Aug; 57(16):6897-918. PubMed ID: 24707857 [TBL] [Abstract][Full Text] [Related]
6. THP-1 Cells and Pro-inflammatory Cytokine Production: An in Vitro Tool for Functional Characterization of NOD1/NOD2 Antagonists. Jakopin Ž; Corsini E Int J Mol Sci; 2019 Aug; 20(17):. PubMed ID: 31480368 [TBL] [Abstract][Full Text] [Related]
7. E-selectin expression induced by Porphyromonas gingivalis in human endothelial cells via nucleotide-binding oligomerization domain-like receptors and Toll-like receptors. Wan M; Liu JR; Wu D; Chi XP; Ouyang XY Mol Oral Microbiol; 2015 Oct; 30(5):399-410. PubMed ID: 25939768 [TBL] [Abstract][Full Text] [Related]
8. NOD1 and NOD2 Are Potential Therapeutic Targets for Cancer Immunotherapy. Wang D Comput Intell Neurosci; 2022; 2022():2271788. PubMed ID: 36262606 [TBL] [Abstract][Full Text] [Related]
9. NOD1 and NOD2 signalling links ER stress with inflammation. Keestra-Gounder AM; Byndloss MX; Seyffert N; Young BM; Chávez-Arroyo A; Tsai AY; Cevallos SA; Winter MG; Pham OH; Tiffany CR; de Jong MF; Kerrinnes T; Ravindran R; Luciw PA; McSorley SJ; Bäumler AJ; Tsolis RM Nature; 2016 Apr; 532(7599):394-7. PubMed ID: 27007849 [TBL] [Abstract][Full Text] [Related]
10. Identification of indole scaffold-based dual inhibitors of NOD1 and NOD2. Keček Plešec K; Urbančič D; Gobec M; Pekošak A; Tomašič T; Anderluh M; Mlinarič-Raščan I; Jakopin Ž Bioorg Med Chem; 2016 Nov; 24(21):5221-5234. PubMed ID: 27601373 [TBL] [Abstract][Full Text] [Related]
12. The role of nucleotide-binding oligomerization domain 1 during cytokine production by macrophages in response to Mycobacterium tuberculosis infection. Lee JY; Hwang EH; Kim DJ; Oh SM; Lee KB; Shin SJ; Park JH Immunobiology; 2016 Jan; 221(1):70-5. PubMed ID: 26255090 [TBL] [Abstract][Full Text] [Related]
13. Up-regulation of NOD1 and NOD2 through TLR4 and TNF-alpha in LPS-treated murine macrophages. Takahashi Y; Isuzugawa K; Murase Y; Imai M; Yamamoto S; Iizuka M; Akira S; Bahr GM; Momotani E; Hori M; Ozaki H; Imakawa K J Vet Med Sci; 2006 May; 68(5):471-8. PubMed ID: 16757890 [TBL] [Abstract][Full Text] [Related]
14. Cell-based reporter assay to analyze activation of Nod1 and Nod2. Zurek B; Bielig H; Kufer TA Methods Mol Biol; 2011; 748():107-19. PubMed ID: 21701969 [TBL] [Abstract][Full Text] [Related]
15. Structural features and functional activities of benzimidazoles as NOD2 antagonists. Guzelj S; Gobec M; Urbančič D; Mlinarič-Raščan I; Corsini E; Jakopin Ž Eur J Med Chem; 2020 Mar; 190():112089. PubMed ID: 32014680 [TBL] [Abstract][Full Text] [Related]
16. Nod1 and Nod2 induce CCL5/RANTES through the NF-kappaB pathway. Werts C; le Bourhis L; Liu J; Magalhaes JG; Carneiro LA; Fritz JH; Stockinger S; Balloy V; Chignard M; Decker T; Philpott DJ; Ma X; Girardin SE Eur J Immunol; 2007 Sep; 37(9):2499-508. PubMed ID: 17705131 [TBL] [Abstract][Full Text] [Related]
17. NOD-like receptors (NLRs): bona fide intracellular microbial sensors. Shaw MH; Reimer T; Kim YG; Nuñez G Curr Opin Immunol; 2008 Aug; 20(4):377-82. PubMed ID: 18585455 [TBL] [Abstract][Full Text] [Related]
18. Synthesis of conformationally constrained γ-D-glutamyl-meso-diaminopimelic acid derivatives as ligands of nucleotide-binding oligomerization domain protein 1 (Nod1). Jakopin Ž; Gobec M; Kodela J; Hazdovac T; Mlinarič-Raščan I; Sollner Dolenc M Eur J Med Chem; 2013 Nov; 69():232-43. PubMed ID: 24044936 [TBL] [Abstract][Full Text] [Related]
19. NOD1, a new player in cardiac function and calcium handling. Delgado C; Ruiz-Hurtado G; Gómez-Hurtado N; González-Ramos S; Rueda A; Benito G; Prieto P; Zaragoza C; Delicado EG; Pérez-Sen R; Miras-Portugal MT; Núñez G; Boscá L; Fernández-Velasco M Cardiovasc Res; 2015 Jun; 106(3):375-86. PubMed ID: 25824149 [TBL] [Abstract][Full Text] [Related]
20. Structural and functional insights into CARDs of zebrafish (Danio rerio) NOD1 and NOD2, and their interaction with adaptor protein RIP2. Maharana J; Dehury B; Sahoo JR; Jena I; Bej A; Panda D; Sahoo BR; Patra MC; Pradhan SK Mol Biosyst; 2015 Aug; 11(8):2324-36. PubMed ID: 26079944 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]